LLY vs BDX
By Alex · Tickerpine
Eli Lilly and Company vs Becton, Dickinson and Company, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | BDX |
|---|---|---|
| Price | $1,443.50 | $218.03 |
| Market cap | $1.29T | $59.39B |
| P/E ratio | 46.9 | 43.1 |
| ROE | 86.02% | 5.66% |
| Profit margin | 31.90% | 5.88% |
| Revenue growth | 38.60% | -10.50% |
| Dividend yield | 0.48% | 1.94% |
| Beta | 0.39 | 0.28 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs BDX in plain English
- LLY is the bigger company — about 21.7× the market cap of BDX.
- BDX is cheaper on earnings (P/E 43.1 vs 46.9).
- LLY earns a higher return on equity (86% vs 6%).
- LLY is growing revenue faster (39% vs -10%).
- BDX has the higher dividend yield (1.94% vs 0.48%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
BDX return calculator
See what $1,000 in Becton, Dickinson and Company would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.